CAFs in colorectal, endometrial, and oesophageal cancers contribute to the secretion of Wnt5a, Wnt1, Wnt10b, and Wnt2, further promoting tumour proliferation, migration and relapse by activating canonical/noncanonical Wnt pathways [71,72,73,74]. Here, WNT2 is linked to neoplasm.